Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Astrid C P Swinkels

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Studies in Health Technology and Informatics|August 23, 2024
Development and Implementation of Semantic Information Standards for OncologyKees C W J Ebben, Lonneke R E Vermeulen, Astrid C P Swinkels, et al.
Studies in Health Technology and Informatics|August 23, 2024
Development and Implementation of Standardized, Structured Clinical Reporting for OncologyKees C W J Ebben, Astrid C P Swinkels, Marijke M A Dermois, et al.
Eclinicalmedicine|March 30, 2023
Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trialVivianne C G Tjan-Heijnen, Senna W M Lammers, Sandra M E Geurts, et al.
JNCI Cancer Spectrum|November 22, 2023
The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancerSenna W M Lammers, Sandra M E Geurts, Irene E G van Hellemond, et al.
Breast Cancer Research and Treatment|June 28, 2024
Ovarian function recovery in breast cancer patients receiving adjuvant anastrozole treatment: updated results from the phase 3 DATA trialSenna W M Lammers, Sandra M E Geurts, Karlijn E P E Hermans, et al.
Breast Cancer Research and Treatment|March 4, 2020
Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trialIrene E G van Hellemond, Carolien H Smorenburg, Petronella G M Peer, et al.
The Lancet. Oncology|October 17, 2017
Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trialVivianne C G Tjan-Heijnen, Irene E G van Hellemond, Petronella G M Peer, et al.
International Journal of Cancer|February 13, 2019
Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA studyIrene E G van Hellemond, Carolien H Smorenburg, Petronella G M Peer, et al.
International Journal of Cancer|December 28, 2018
Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy-induced ovarian function failureIrene E G van Hellemond, Ingeborg J H Vriens, Petronella G M Peer, et al.
Nature|July 22, 2025
Author Correction: Early versus deferred use of CDK4/6 inhibitors in advanced breast cancerGabe S Sonke, Annemiek van Ommen-Nijhof, Noor Wortelboer, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Studies in Health Technology and Informatics|August 23, 2024
Development and Implementation of Semantic Information Standards for OncologyKees C W J Ebben, Lonneke R E Vermeulen, Astrid C P Swinkels, et al.
Studies in Health Technology and Informatics|August 23, 2024
Development and Implementation of Standardized, Structured Clinical Reporting for OncologyKees C W J Ebben, Astrid C P Swinkels, Marijke M A Dermois, et al.
Eclinicalmedicine|March 30, 2023
Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trialVivianne C G Tjan-Heijnen, Senna W M Lammers, Sandra M E Geurts, et al.
JNCI Cancer Spectrum|November 22, 2023
The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancerSenna W M Lammers, Sandra M E Geurts, Irene E G van Hellemond, et al.
Breast Cancer Research and Treatment|June 28, 2024
Ovarian function recovery in breast cancer patients receiving adjuvant anastrozole treatment: updated results from the phase 3 DATA trialSenna W M Lammers, Sandra M E Geurts, Karlijn E P E Hermans, et al.
Breast Cancer Research and Treatment|March 4, 2020
Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trialIrene E G van Hellemond, Carolien H Smorenburg, Petronella G M Peer, et al.
The Lancet. Oncology|October 17, 2017
Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trialVivianne C G Tjan-Heijnen, Irene E G van Hellemond, Petronella G M Peer, et al.
International Journal of Cancer|February 13, 2019
Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA studyIrene E G van Hellemond, Carolien H Smorenburg, Petronella G M Peer, et al.
International Journal of Cancer|December 28, 2018
Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy-induced ovarian function failureIrene E G van Hellemond, Ingeborg J H Vriens, Petronella G M Peer, et al.
Nature|July 22, 2025
Author Correction: Early versus deferred use of CDK4/6 inhibitors in advanced breast cancerGabe S Sonke, Annemiek van Ommen-Nijhof, Noor Wortelboer, et al.
Pageof 2